Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q1- Text added to 2020 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Abbvie, acute, adult, AKS, Amgen, Army, beneficiary, Biomarck, biomarker, Bioscience, biosimilar, Biotech, border, bring, broadened, broadly, capture, Children, Command, committed, concealing, Consortium, Corrupt, covertly, COVID, custody, defraud, device, dexamethasone, diurnal, dollar, drawn, Edesa, endothelial, exacerbated, exploratory, fact, false, falsifying, family, fashion, FCA, FCPA, gave, HIPAA, HITECH, hypothesize, imprisonment, improperly, inappropriate, inconsistent, IND, induce, ineffective, kind, knowingly, lawsuit, Leap, light, Lilly, loosening, low, magnified, mentioned, microvascular, MIDRP, Military, moderate, monotherapy, MTEC, nurse, omitted, ophthalmic, overtly, physician, play, Portability, proceed, profile, prolonged, purpose, Quantum, quarantine, rapid, razuprotafib, receptor, recovery, Regeneron, regular, relax, remdesivir, remuneration, respiratory, role, rollback, scheme, scrutiny, Serial, solution, Sunshine, syndrome, transmission, transmit, trick, unfair, whistleblower
Valuein 2020 Q1 filing- Value in 2020 Q2 filing
Original filings
Filing view